First-line bevacizumab combined with reduced dose interferon- 2a is active in patients with metastatic renal cell carcinoma

标题
First-line bevacizumab combined with reduced dose interferon- 2a is active in patients with metastatic renal cell carcinoma
作者
关键词
-
出版物
ANNALS OF ONCOLOGY
Volume 19, Issue 8, Pages 1470-1476
出版商
Oxford University Press (OUP)
发表日期
2008-04-13
DOI
10.1093/annonc/mdn161

向作者/读者发起求助以获取更多资源

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now